Japan Lifeline has filed a patent for a power supply device designed for ablation using irreversible electroporation. The device includes a power source unit and a control unit to deliver pulse voltages with various positive amplitude values to multiple electrodes in an ablation catheter. GlobalData’s report on Japan Lifeline gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Japan Lifeline, Surgical robots was a key innovation area identified from patents. Japan Lifeline's grant share as of January 2024 was 16%. Grant share is based on the ratio of number of grants to total number of patents.
Power supply device for ablation using irreversible electroporation
See Also:
The patent application (Publication Number: US20240016536A1) describes a power supply device for use in ablation procedures utilizing irreversible electroporation. The device includes a power source unit that supplies power to multiple electrodes in an ablation catheter and a control unit that regulates pulse voltages applied to these electrodes during the ablation process. Specifically, the control unit ensures that pulse voltages with various positive amplitude values are applied to three or more application electrodes, maintaining specific thresholds for amplitude value differences and electric field intensity between adjacent electrodes.
Furthermore, the patent application also covers an ablation system incorporating the described power supply device and an ablation catheter with multiple electrodes. The system is designed for treating arrhythmias by performing ablation on affected areas within a patient's body using irreversible electroporation. The power supply device within the system controls the pulse voltages applied to the electrodes, ensuring the appropriate distribution of power for effective ablation while maintaining specific thresholds for amplitude value differences and electric field intensity. This innovation aims to enhance the precision and efficacy of ablation procedures, particularly in the treatment of arrhythmias.
To know more about GlobalData’s detailed insights on Japan Lifeline, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
